09:06 AM EDT, 08/01/2024 (MT Newswires) -- Ionis Pharmaceuticals ( IONS ) reported a Q2 loss Thursday of $0.45 per diluted share, narrowing from a loss of $0.60 a year earlier.

Analysts polled by Capital IQ expected a loss of $0.91.

Revenue for the quarter ended June 30 was $225 million, up from $188 million a year earlier.

Analysts surveyed by Capital IQ expected $149.8 million.

The company's shares were up more than 2% in recent Thursday premarket activity.

Price: 50.65, Change: +1.19, Percent Change: +2.41